SignalRX Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: San Diego CA United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2012
NCT00907205
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now